The best drug references just got better. Implications Valganciclovir is converted to ganciclovir and shares its reproductive toxicity. Safety and efficacy have not been established in pediatric patients.
Treatment is supportive.
Hydration may be of some benefit. Drug interaction studies have not been conducted with valganciclovir. The following interactions have been described for ganciclovir. Since both drugs have the potential to cause neutropenia and anemia, some patients may not tolerate concomitant therapy with these drugs at full dosage. The bioavailability of ganciclovir from valganciclovir is increased tenfold compared to the oral ganciclovir.